Global Hematuria Treatment Market Size & Outlook, 2025-2033
Global hematuria treatment market, 2021-2033 (US$M)
Global hematuria treatment market highlights
- The global hematuria treatment market generated a revenue of USD 1,087.3 million in 2024 and is expected to reach USD 1,426.9 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 3.1% by 2033.
- In terms of segment, pharmacotherapy accounted for a revenue of USD 1,119.7 million in 2024.
- Pharmacotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 1,087.3 million |
| Market revenue in 2033 | USD 1,426.9 million |
| Growth rate | 3.1% (CAGR from 2025 to 2033) |
| Largest segment | Pharmacotherapy |
| Fastest growing segment | Pharmacotherapy |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmacotherapy |
Other key industry trends
- In terms of revenue, the North America accounted for 42.7% of the global hematuria treatment market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hematuria Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Global hematuria treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hematuria treatment market will help companies and investors design strategic landscapes.
Pharmacotherapy was the largest segment with a revenue share of 102.98% in 2024. Horizon Databook has segmented the Global hematuria treatment market based on pharmacotherapy covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Hematuria Treatment Treatment Type Outlook (Revenue, USD Million, 2021-2033)
- Pharmacotherapy
- Procedural / Interventional Therapies
- Adjunctive / Supportive Therapies
- Global Hematuria Treatment Type Outlook (Revenue, USD Million, 2021-2033)
- Branded
- Generic
Reasons to subscribe to Global hematuria treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global hematuria treatment market databook
-
Our clientele includes a mix of hematuria treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global hematuria treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global hematuria treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global hematuria treatment market size, by regions, 2021-2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
